Zhengyuan is devoted to providing leading technologies,products and service in its strategic business of medical 

Aerosol therapy widely researched and used in America, Europe and Japan is a effective way of targeted delivery.It is preffered by WHO and GINA to be the first choice in the therapy or respiratory system disease such as asthma, COPD and etc. Due to our core technologies and registered patents in the key process of making inhalation devices, our company plans to make innovation of the drug delivery of the prevention and treatment of respiratory system disease,infection disease,metabolic disease, body surface disease and human vaccine, which makes painless and convenient drug delivery to be accepted by the public.

Based on the foundation and creative design in the R&D of inhalation devices, our products have reached or exceeded the advanced level of Germany,USA,UK and Japan. Conclusive validation acquired by foreign and domestic pharmaceutical companies in more clinical trails than any other brand.